Institute of Oncology Prof. Dr. Ion Chiricuta
In research, Institute of Oncology Prof. Dr. Ion Chiricuta stands highest in Medicine (#7,290 of 10,443 worldwide) and Health Sciences (#9,121 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 12.4× its share of world research.
- World rank, 2022–2025
- #12,338 of 28,054 · #17,219 all time
- Rank in Romania
- #58 of 126
- Research works
- 724 ▲ 45% vs 2013–17
- Citations
- 13k 17.8 per fractional work
- Top-10% rate
- 16.9% record average 16.5%
- Open access
- 55% world 28%
What is Institute of Oncology Prof. Dr. Ion Chiricuta known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,290 of 10,443 | 15.0% | 92 | #9038 | |
| Health SciencesDomain | #9,121 of 11,982 | 15.0% | 94 | #11718 |
Each strip is that field’s whole ranked pool, with the notch where Institute of Oncology Prof. Dr. Ion Chiricuta sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institute of Oncology Prof. Dr. Ion Chiricuta specialise in?
Where its research is concentrated relative to its size: Oncology takes 12.4× the share of its output that it takes of world research.
- OncologySubfield · 20.7 works12×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.0×
- Medicine 3.2×
- Immunology and Microbiology 2.7×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Neuroscience 1.1×
- Dentistry 0.8×
- Chemistry 0.7×
- Economics, Econometrics and Finance 0.6×
- Nursing 0.5×
- Psychology 0.4×
- Agricultural and Biological Sciences 0.3×
- Materials Science 0.3×
- Physics and Astronomy 0.2×
- Engineering 0.2×
- Mathematics 0.1×
- Health Professions 0.1×
- Decision Sciences 0.1×
- Arts and Humanities 0.1×
- Environmental Science 0.1×
- Computer Science 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Institute of Oncology Prof. Dr. Ion Chiricuta?
Ranked on the composite score, Tudor–Eliade Ciuleanu, Patriciu Achimaș-Cădariu and Ovidiu Bălăcescu lead among researchers whose main affiliation is Institute of Oncology Prof. Dr. Ion Chiricuta.
- 1 Tudor–Eliade Ciuleanu Romania · #13,774 worldwide 548 citations · 51 works
- 2 Patriciu Achimaș-Cădariu Romania · #257,286 worldwide 57 citations · 29 works
- 3 Ovidiu Bălăcescu Romania · #320,911 worldwide 118 citations · 18 works
- 4 Alexandru Eniu Romania · #342,001 worldwide 70 citations · 23 works
- 5 I Kiricuţă Romania · #482,848 worldwide 32 citations · 17 works
- 6 Paul Kubelac Romania · #1,072,707 worldwide 9 citations · 17 works
- 7 N. Todor Romania · #1,166,495 worldwide 11 citations · 19 works
- 8 Alexandru Irimie Romania · #1,173,699 worldwide 25 citations · 20 works
- 9 Delia Dima Romania · #1,307,842 worldwide 13 citations · 16 works
- 10 Cătălin Vlad Romania · #1,366,240 worldwide 8 citations · 17 works
Which keywords describe research at Institute of Oncology Prof. Dr. Ion Chiricuta?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Biomarkers, Prognostic Factors, Immunotherapy, Metastasis, Clinical Practice Guidelines and Radiotherapy.
- Cancer Risk
- MicroRNA
- Genomic Instability
- Cancer Biomarkers
- Adjuvant Chemotherapy
- Prognostic Markers
- Cancer Incidence
- Molecular Subtypes
- Genetic Mutations
- Cancer Therapy
- Breast Cancer
- Targeted Therapy
- Survival Analysis
- Regulation
- Biogenesis
- Radiotherapy
- Inflammation
- Metastasis
- Prognostic Factors
- Chemotherapy
- Cancer
- Biomarkers
- Immunotherapy
- Epidemiology
- Clinical Practice Guidelines
- Clinical Trials
- Gene Expression
- Tumor Microenvironment
- Precision Medicine
- Neoadjuvant Therapy
- Molecular Characterization
- Ovarian Cancer
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Cervical Cancer
- Cellular Functions
- BRAF Mutation
- Cytoreductive Surgery
- Human Papillomavirus
- Targeting
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer14▲ 7.3×30 topics
- Chemotherapy13▲ 13×19 topics
- Biomarkers10▲ 9.6×13 topics
- Prognostic Factors9▲ 13×12 topics
- Immunotherapy8▲ 8.1×14 topics
- Metastasis8▲ 17×9 topics
- Epidemiology8▲ 1.42×28 topics
- Inflammation8▲ 2.6×36 topics
- Clinical Practice Guidelines8▲ 9.6×8 topics
- Radiotherapy8▲ 13×9 topics
- Clinical Trials7▲ 7.1×9 topics
- Biogenesis7▲ 27×3 topics
- Gene Expression7▲ 7.7×10 topics
- Regulation7▲ 8.4×7 topics
- Tumor Microenvironment6▲ 9.9×7 topics
- Survival Analysis6▲ 15×6 topics
- Precision Medicine5▲ 7.6×6 topics
- Targeted Therapy5▲ 16×4 topics
- Neoadjuvant Therapy5▲ 15×5 topics
- Breast Cancer5▲ 13×11 topics
- Molecular Characterization5▲ 17×4 topics
- Cancer Therapy4▲ 4.9×14 topics
- Ovarian Cancer4▲ 31×3 topics
- Genetic Mutations4▲ 6.2×11 topics
- Immune Checkpoint Blockade4▲ 22×1 topic
- Molecular Subtypes4▲ 30×2 topics
- PD-1 and PD-L14▲ 22×1 topic
- Cancer Incidence4▲ 17×4 topics
- Cervical Cancer4▲ 23×3 topics
- Prognostic Markers4▲ 22×3 topics
- Cellular Functions3▲ 31×2 topics
- Adjuvant Chemotherapy3▲ 31×2 topics
- BRAF Mutation3▲ 28×2 topics
- Cancer Biomarkers3▲ 23×3 topics
- Cytoreductive Surgery3▲ 30×2 topics
- Genomic Instability3▲ 17×3 topics
- Human Papillomavirus3▲ 16×3 topics
- MicroRNA3▲ 16×1 topic
- Targeting3▲ 26×1 topic
- Cancer Risk3▲ 8.6×4 topics
Which research topics does Institute of Oncology Prof. Dr. Ion Chiricuta publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, MicroRNA in disease regulation, Ovarian cancer diagnosis and treatment and Circular RNAs in diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 2 MicroRNA in disease regulation Cancer Research 3 works
- 3 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
- 4 Circular RNAs in diseases Molecular Biology 2 works
- 5 Cancer Genomics and Diagnostics Cancer Research 2 works
- 6 Acute Myeloid Leukemia Research Hematology 2 works
- 7 Breast Cancer Treatment Studies Cancer Research 2 works
- 8 Colorectal Cancer Surgical Treatments Oncology 2 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 10 Cervical Cancer and HPV Research Epidemiology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute of Oncology Prof. Dr. Ion Chiricuta's research output changed?
Output in 2018–2022 was 45% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cluj-Napoca
- Babeș-Bolyai University
- Technical University of Cluj-Napoca
- Iuliu Hațieganu University of Medicine and Pharmacy
- University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca
- National Institute for Research and Development of Isotopic and Molecular Technologies
- Spitalul Clinic de Recuperare
- Sapientia Hungarian University of Transylvania
- Spitalul Clinic Județean de Urgență Cluj-Napoca
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.